Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barford

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Journal of Medicinal Chemistry|April 25, 2007
Identification of inhibitors of protein kinase B using fragment-based lead discoveryGordon Saxty, Steven J Woodhead, Valerio Berdini, et al.
Nature Communications|November 18, 2022
Biasing the conformation of ELMO2 reveals that myoblast fusion can be exploited to improve muscle regenerationViviane Tran, Sarah Nahlé, Amélie Robert, et al.
Journal of Molecular Biology|February 6, 2007
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimeraThomas G Davies, Marcel L Verdonk, Brent Graham, et al.
Cell|March 24, 2004
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAFPaul T C Wan, Mathew J Garnett, S Mark Roe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTPKaterina Naydenova, Kyle W Muir, Long-Fei Wu, et al.
Science (New York, N.Y.)|May 29, 2004
A family with severe insulin resistance and diabetes due to a mutation in AKT2Stella George, Justin J Rochford, Christian Wolfrum, et al.
Cancer Research|August 1, 2022
Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial CancerOwen J Chen, Ester Castellsagué, Mohamed Moustafa-Kamal, et al.
Cell|November 12, 2013
KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidationLaura R Pearce, Neli Atanassova, Matthew C Banton, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Journal of Medicinal Chemistry|April 25, 2007
Identification of inhibitors of protein kinase B using fragment-based lead discoveryGordon Saxty, Steven J Woodhead, Valerio Berdini, et al.
Nature Communications|November 18, 2022
Biasing the conformation of ELMO2 reveals that myoblast fusion can be exploited to improve muscle regenerationViviane Tran, Sarah Nahlé, Amélie Robert, et al.
Journal of Molecular Biology|February 6, 2007
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimeraThomas G Davies, Marcel L Verdonk, Brent Graham, et al.
Cell|March 24, 2004
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAFPaul T C Wan, Mathew J Garnett, S Mark Roe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTPKaterina Naydenova, Kyle W Muir, Long-Fei Wu, et al.
Science (New York, N.Y.)|May 29, 2004
A family with severe insulin resistance and diabetes due to a mutation in AKT2Stella George, Justin J Rochford, Christian Wolfrum, et al.
Cancer Research|August 1, 2022
Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial CancerOwen J Chen, Ester Castellsagué, Mohamed Moustafa-Kamal, et al.
Cell|November 12, 2013
KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidationLaura R Pearce, Neli Atanassova, Matthew C Banton, et al.
Pageof 12